TL011 in Severe, Active Rheumatoid Arthritis Patients
- Study Title
- TL011 in Severe, Active Rheumatoid Arthritis Patients
- Teva Identifier
- RA-TL011-101 | 2009-015702-18
- ClinicalTrials.gov Identifier
- NCT01123070
- Study Status
- Completed
- Trial Condition(s)
- Rheumatoid Arthritis
- Interventions
- Biological: TL011, anti CD20, for the treatment of rheumatoid arthritis | Biological: MabThera infusions
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 80 Years
- Trial Duration
- 02/01/2010 - 05/01/2012
- Phase
- Phase 1/2
